Blocking impact of clozapine on cocaine locomotor and sensitizing effects in rats

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 1125-1130

  Filip, Małgorzata ^a   Papla, Iwona ^a   Nowak, Ewa ^a   Przegaliński, Edmund ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Behavioral sensitization; Clozapine; Cocaine; Locomotor activation; Rats

Indexed keywords

ACETIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; COCAINE; PSYCHOSTIMULANT AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL STUDY; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG RESPONSE; DRUG SENSITIZATION; DRUG WITHDRAWAL; GENDER; HUMAN; LOCOMOTION; MALE; NONHUMAN; PROVOCATION TEST; RAT; RAT STRAIN; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TIME;

ANIMALS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CLOZAPINE; COCAINE; DRUG TOLERANCE; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2;

EID: 1642543877     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Boess F.G., Martin I.L.: Molecular biology of 5-HT receptors. Neuropharmacology, 1994, 33, 275-317.
2. 2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Eur. J. Pharmacol., 2002, 453, 255-263.
3. (1A) agonist 8-hydroxy-2-(din-propylamino tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J. Pharmacol. Exp. Ther., 2000, 292, 610-617.
4. 1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics. Synapse, 2002, 43, 51-61.
5. Farren C.K., Hameedi F.A., Rosen M.A., Woods S., Jatlow P., Kosten T.R.: Significant interaction between clozapine and cocaine in cocaine addicts. Drug Alcohol Dependence, 2000, 59, 153-163.
6. 2A/2C receptors in the sensitization to cocaine. J. Physiol. Pharmacol., 2001, 52, 471-481.
7. 3 receptors in controlling the expression of cocaine sensitization in rats. Pol. J. Pharmacol., 2002, 54, 687-691.
8. Hall H., Sallemark M., Jerning E.: Effects of remoxipride and some related new substituted salicylamides on rat brain receptors. Acta Pharmacol. Toxicol., 1986, 58, 61-70.
9. Heidbreder C.A., Shippenberg T.S.: Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse, 1996, 24, 182-192.
10. Hoyer D., Hannon J.P., Martin G.R.: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav., 2002, 71, 533-554.
11. Kelly P.H., Iversen S.D.: Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol., 1976, 40, 45-56.
12. 3 receptor antagonist. Eur. J. Pharmacol., 2000, 394, 97-101.
13. 3 receptor antagonist, and cocaine. Psychopharmacology, 1997, 130, 159-165.
14. Klein M.: Research issues related to development of medications for treatment of cocaine addiction. Ann. NY Acad. Sci., 1998, 844, 75-91.
15. Koe B.K.: Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther., 1976, 199, 649-661.
16. Kosten T.A., Nestler E.J.: Clozapine attenuates cocaine conditioned place preference. Life Sci., 1994, 55, 9-14.
17. Kuczenski R., Segal D.S.: Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther., 1992, 262, 1085-1094.
18. 2 receptor antagonists on ethanol- and cocaine-induced locomotion. Pharmacol. Biochem. Behav., 1997, 57, 325-332.
19. Loh E.A., Fitch T., Vickers G., Roberts D.C.: Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine. Pharmacol. Biochem. Behav., 1992, 42, 559-562.
20. Lysaker P., Bell M., Beam-Goulet J., Milstein R.: Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J. Nerv. Ment. Dis., 1994, 182, 109-112.
21. Martin-Iverson M.T., Reimer A.R.: Effects of nimodipine and/or haloperidol on the expression of conditioned locomotion and sensitization to cocaine in rats. Psychopharmacology, 1994, 114, 315-320.
22. 2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology, 1994, 114, 239-242.
23. McCreary A.C., Callahan P.M., Cunningham K.A.: GR 127935 differentially modulates the locomotor and discriminative stimulus effects of cocaine. 60th Annual CPDD Meeting, Scottsdale AZ, 1997.
24. 1 receptor antagonism by SCH 23390 prevents expression of conditioned sensitisation following repeated administration of cocaine. Neuropharmacology, 1993, 32, 387-391.
25. 2A receptors attenuates the behavioral effects of cocaine in rats. J. Pharmacol. Exp. Ther., 2001, 297, 357-363.
26. Meltzer H.Y.: The mechanism of action of novel antipsychotic drugs. Schizophr. Bull., 1991, 17, 263-287.
27. Mueser K.T., Yarnold P.R., Levinson D.F., Singh H., Bellack A.S., Kee K., Morrison R.L., Yadalam K.G.: Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull., 1990, 16, 31-56.
28. Pierce R.C., Kalivas P.W.: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev., 1997, 25, 192-216.
29. Pietraszek M.: Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms. Pol. J. Pharmacol., 2003, 55, 133-154.
30. 1B receptor ligands on cocaine sensitization in rats. Behav. Pharmacol., 2001, 12, 109-116.
31. 1A receptors inhibits amphetamine sensitization in mice. Life Sci., 2000, 66, 1011-1019.
32. 3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur. J. Pharmacol., 1990, 186, 327-330.
33. Ritz M.C., Cone E.J., Kuhar M.J.: Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci., 1990, 46, 635-645.
34. Roberts D.C., Vickers G.: Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioural screen for antipsychotic activity. Psychopharmacology, 1984, 82, 135-139.
35. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J. Jr, Shen Y., Meltzer H.Y., Sibley D.R.: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 1994, 268, 1403-1410.
36. Tang A.H., Franklin S.R., Himes C.S., Smith M.W., Tenbrink R.E.: PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. J. Pharmacol. Exp. Ther., 1997, 281, 440-447.
37. Tella S.R.: Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol. Biochem. Behav., 1994, 48, 151-159.
38. Van Campenhout N., De Haes P., Meert T.F.: Inability of antipsychotics to antagonize the cueing properties of cocaine in rats. Pharmacol. Biochem. Behav., 1999, 64, 435-438.
39. Vanderschuren L.J., Beemster P., Schoffelmeer A.N.: On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization. Psychopharmacology, 2003, 169, 176-185.
40. Vanover K.E., Piercey M.F., Woolverton W.L.: Evaluation of the reinforcing and discriminative stimulus effects of cocaine in combination with (+)-AJ76 or clozapine. J. Pharmacol. Exp. Ther., 1993, 266, 780-789.
41. White F.J., Joshi A., Koeltzow T.E., Hu X.T.: Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology, 1998, 18, 26-40.
42. Yovell Y., Opler L.A.: Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis. J. Nerv. Ment. Dis., 1994, 182, 591-592.